{
  "Study_ID": "Khurana2012",
  "First_Author": "Khurana N",
  "Year": "2012",
  "Country": "India",
  "Study_Design": "Open label randomized trial",
  "Risk_of_Bias": "Moderate - open label but computer-generated randomization",
  "Diagnostic_Criteria": "New-onset seizures (<14 days), single enhancing lesion <20mm on CT, no neurological deficits",
  "Total_Sample_Size": "105",
  "Treatment_Group_N": "35 (3-day), 35 (15-day)",
  "Control_Group_N": "35 (no albendazole)",
  "Age_Mean_SD": "16.73 Â± 10.1 years (range 3.5-50)",
  "Male_Percentage": "71.4 (75/105)",
  "Female_Percentage": "28.6 (30/105)",
  "Other_Demographics": "63% less than 18 years old",
  "Headache_Percentage": "Not reported",
  "Focal_Seizures_Percentage": "71.4% (partial with/without secondary generalization)",
  "Other_Symptoms": "One patient had status epilepticus",
  "Treatment_Type": "3-day vs 15-day albendazole vs no treatment",
  "Albendazole_Dose": "15 mg/kg/day in two divided doses",
  "Treatment_Duration_Days": "3 or 15",
  "Number_of_Cycles": "1",
  "Cycle_Interval_Days": "Not applicable",
  "Praziquantel_Dose": "Not used",
  "Corticosteroid_Type": "No steroids used",
  "Antiepileptic_Drug": "Oxcarbazepine (10mg/kg/day in children, 600mg twice daily in adults)",
  "Follow_up_Duration_Months": "6",
  "Imaging_Schedule": "Baseline CT, MRI at 6 months",
  "Complete_Resolution_Percentage": "37.14% (control), 54.29% (3-day), 68.57% (15-day)",
  "Partial_Resolution_Percentage": "28.57% (control), 25.71% (3-day), 28.57% (15-day)",
  "No_Change_Percentage": "62.86% (control), 45.71% (3-day), 31.43% (15-day)",
  "Seizure_Reduction_Percentage": "Seizure recurrence: 22.85% (control), 22.85% (3-day), 11.43% (15-day), p=0.37",
  "Elevated_Liver_Enzymes_Percentage": "Not reported",
  "Other_AE": "One patient developed drug-induced rash to oxcarbazepine",
  "Comments": "15-day albendazole was significantly better than control for lesion resolution (p=0.03). Lower calcification rates with longer treatment. No significant difference in seizure recurrence between groups.",
  "last_modified": "2024-10-31T14:56:19.234545"
}